EFFICACY AND SAFTY OF DAPAGLIFLOZIN FOR HEART FAILURE: A SYSTEMIC REVIEW

被引：0
|
作者：
Wang, Zhe [1 ]
机构：
[1] Tianjin Med Univ, Second Hosp, Blood Purificat, Tianjin, Peoples R China
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO723
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Safety of Dapagliflozin in Children with Heart Failure
    Newland, D. M.
    Hong, B. J.
    Albers, E. L.
    Friedland-Little, J. M.
    Kemna, M. S.
    Law, Y. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S280 - S280
  • [22] EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE
    Abdullaev, Sherzod
    Sharapov, Olimkhon
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I462 - I462
  • [23] Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index
    Adamson, Carly
    Jhund, Pardeep S.
    Docherty, Kieran F.
    Belohlavek, Jan
    Chiang, Chern-En
    Diez, Mirta
    Drozdz, Jaroslaw
    Dukat, Andrej
    Howlett, Jonathan
    Ljungman, Charlotta E. A.
    Petrie, Mark C.
    Schou, Morten
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Solomon, Scott D.
    Bengtsson, Olof
    Langkilde, Anna Maria
    Lindholm, Daniel
    Sjostrand, Mikaela
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (10) : 1662 - 1672
  • [24] Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction
    Docherty, Kieran F.
    Ogunniyi, Modele O.
    Anand, Inder S.
    Desai, Akshay S.
    Diez, Mirta
    Howlett, Jonathan G.
    Nicolau, Jose C.
    O'Meara, Eileen
    Verma, Subodh
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Lindholm, Daniel
    Martinez, Felipe A.
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Langkilde, Anna Maria
    Jhund, Pardeep S.
    McMurray, John J., V
    JACC-HEART FAILURE, 2022, 10 (01) : 52 - 64
  • [25] Influence of background therapy on efficacy of dapagliflozin in patients with heart failure and improved ejection fraction
    Porras, M. A. Pabon
    Clagget, B. L.
    Chatur, S.
    Bhatt, A. S.
    Vaduganathan, M.
    Fang, J.
    Desai, A.
    Jhund, P.
    Martinez, F.
    De Boer, R.
    Kosiborod, M.
    Lam, C.
    Mcmurray, J.
    Solomon, S.
    Vaderny, O.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [26] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and concomitant heart failure
    Kosiborod, M.
    Gause-Nilsson, I.
    Sonesson, C.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S368 - S368
  • [27] Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus
    Berg, D.
    Wiviott, S.
    Scirica, B.
    Gurmu, Y.
    Mosenzon, O.
    Murphy, S.
    Bhatt, D.
    Leiter, L.
    McGuire, D.
    Wilding, J.
    Johansson, P.
    Langkilde, A.
    Raz, I.
    Braunwald, E.
    Sabatine, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 153 - 153
  • [28] Dapagliflozin in heart failure and type 2 diabetes: Efficacy, cardiac and renal effects, safety
    Yu, Pei-Ling
    Yu, You
    Li, Shuang
    Mu, Bai-Chen
    Nan, Ming-Hua
    Pang, Min
    WORLD JOURNAL OF DIABETES, 2024, 15 (07)
  • [29] Dapagliflozin in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis
    Cai, Ru-ping
    Xu, Yu-li
    Su, Qiang
    CARDIOLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [30] Effect of Dapagliflozin in Patients with Heart Failure: A Systematic Review and Meta-Analysis
    Ali, Ahmed E.
    Mazroua, Muhammad Sabry
    Elsaban, Mariam
    Najam, Nadia
    Kothari, Aditi S.
    Mansoor, Taha
    Amal, Tanya
    Lee, Joanna
    Kashyap, Rahul
    GLOBAL HEART, 2023, 18 (01) : 45
12345